Synthesis, selective anti-Helicobacter pylori activity, and cytotoxicity of novel N-substituted-2-oxo-2H-1-benzopyran-3-carboxamides. 2010

Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
Dipartimento di Chimica e Tecnologie del Farmaco, Università 'La Sapienza', P.le A. Moro 5, 00185 Rome, Italy.

N-substituted-3-carboxamido-coumarin derivatives were prepared and evaluated for selective antibacterial activity against 20 isolates of Helicobacter pylori clinical strains, including five metronidazole resistant ones. Some of them possessed the best activity against H. pylori metronidazole resistant strains with MIC values lower than the drug reference (metronidazole). Furthermore, anti-inflammatory activity through the inhibition of the IL-8 production was investigated.

UI MeSH Term Description Entries
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D002460 Cell Line Established cell cultures that have the potential to propagate indefinitely. Cell Lines,Line, Cell,Lines, Cell
D003374 Coumarins Synthetic or naturally occurring substances related to coumarin, the delta-lactone of coumarinic acid. 1,2-Benzopyrone Derivatives,1,2-Benzopyrones,Coumarin Derivative,Coumarine,1,2-Benzo-Pyrones,Benzopyran-2-ones,Coumarin Derivatives,Coumarines,1,2 Benzo Pyrones,1,2 Benzopyrone Derivatives,1,2 Benzopyrones,Benzopyran 2 ones,Derivative, Coumarin,Derivatives, 1,2-Benzopyrone,Derivatives, Coumarin
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000900 Anti-Bacterial Agents Substances that inhibit the growth or reproduction of BACTERIA. Anti-Bacterial Agent,Anti-Bacterial Compound,Anti-Mycobacterial Agent,Antibacterial Agent,Antibiotics,Antimycobacterial Agent,Bacteriocidal Agent,Bacteriocide,Anti-Bacterial Compounds,Anti-Mycobacterial Agents,Antibacterial Agents,Antibiotic,Antimycobacterial Agents,Bacteriocidal Agents,Bacteriocides,Agent, Anti-Bacterial,Agent, Anti-Mycobacterial,Agent, Antibacterial,Agent, Antimycobacterial,Agent, Bacteriocidal,Agents, Anti-Bacterial,Agents, Anti-Mycobacterial,Agents, Antibacterial,Agents, Antimycobacterial,Agents, Bacteriocidal,Anti Bacterial Agent,Anti Bacterial Agents,Anti Bacterial Compound,Anti Bacterial Compounds,Anti Mycobacterial Agent,Anti Mycobacterial Agents,Compound, Anti-Bacterial,Compounds, Anti-Bacterial
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D016209 Interleukin-8 A member of the CXC chemokine family that plays a role in the regulation of the acute inflammatory response. It is secreted by variety of cell types and induces CHEMOTAXIS of NEUTROPHILS and other inflammatory cells. CXCL8 Chemokine,Chemokine CXCL8,Chemotactic Factor, Macrophage-Derived,Chemotactic Factor, Neutrophil, Monocyte-Derived,IL-8,Neutrophil-Activating Peptide, Lymphocyte-Derived,Neutrophil-Activating Peptide, Monocyte-Derived,AMCF-I,Alveolar Macrophage Chemotactic Factor-I,Anionic Neutrophil-Activating Peptide,Chemokines, CXCL8,Chemotactic Factor, Neutrophil,Granulocyte Chemotactic Peptide-Interleukin-8,IL8,Monocyte-Derived Neutrophil Chemotactic Factor,Neutrophil Activation Factor,Alveolar Macrophage Chemotactic Factor I,Anionic Neutrophil Activating Peptide,CXCL8 Chemokines,CXCL8, Chemokine,Chemokine, CXCL8,Chemotactic Factor, Macrophage Derived,Chemotactic Peptide-Interleukin-8, Granulocyte,Granulocyte Chemotactic Peptide Interleukin 8,Interleukin 8,Lymphocyte-Derived Neutrophil-Activating Peptide,Macrophage-Derived Chemotactic Factor,Monocyte-Derived Neutrophil-Activating Peptide,Neutrophil Activating Peptide, Lymphocyte Derived,Neutrophil Activating Peptide, Monocyte Derived,Neutrophil Chemotactic Factor,Neutrophil-Activating Peptide, Anionic,Peptide, Anionic Neutrophil-Activating
D016480 Helicobacter pylori A spiral bacterium active as a human gastric pathogen. It is a gram-negative, urease-positive, curved or slightly spiral organism initially isolated in 1982 from patients with lesions of gastritis or peptic ulcers in Western Australia. Helicobacter pylori was originally classified in the genus CAMPYLOBACTER, but RNA sequencing, cellular fatty acid profiles, growth patterns, and other taxonomic characteristics indicate that the micro-organism should be included in the genus HELICOBACTER. It has been officially transferred to Helicobacter gen. nov. (see Int J Syst Bacteriol 1989 Oct;39(4):297-405). Campylobacter pylori,Campylobacter pylori subsp. pylori,Campylobacter pyloridis,Helicobacter nemestrinae

Related Publications

Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
November 1999, European journal of medicinal chemistry,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
August 2006, Bioorganic & medicinal chemistry letters,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
December 1995, Farmaco (Societa chimica italiana : 1989),
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
June 2010, Yao xue xue bao = Acta pharmaceutica Sinica,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
February 2006, Acta crystallographica. Section C, Crystal structure communications,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
July 2013, European journal of medicinal chemistry,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
August 2020, Bioorganic & medicinal chemistry letters,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
May 2012, Molecules (Basel, Switzerland),
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
July 2007, Journal of medicinal chemistry,
Franco Chimenti, and Bruna Bizzarri, and Adriana Bolasco, and Daniela Secci, and Paola Chimenti, and Arianna Granese, and Simone Carradori, and Daniela Rivanera, and Alessandra Zicari, and M Maddalena Scaltrito, and Francesca Sisto
March 1986, The Journal of antibiotics,
Copied contents to your clipboard!